Stereotaxis (STXS) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/15/2026
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- Fed’s Warsh says central bank won’t tolerate high inflation
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- Lucid Group shares quickly cut in half on report of potential bankruptcy
- HSBC Downgrades IBM (IBM) to Reduce, 'Stretched Valuation'
TD Cowen Reiterates Buy Rating on Stereotaxis (STXS)
August 13, 2024 6:08 AM EDTTD Cowen analyst Joshua Jennings reiterated a Buy rating and $5.00 price target on Stereotaxis (NYSE: STXS).
The analyst comments "While hospital construction delays caused 2Q system sale weakness, there are now multiple systems in transit to customers. STXS projects 2H revenue... More
Roth/MKM Reiterates Buy Rating on Stereotaxis (STXS)
August 13, 2024 5:07 AM EDTRoth/MKM analyst Jason Wittes reiterated a Buy rating and $5.00 price target on Stereotaxis (NYSE: STXS).
The analyst comments "STXS reported 2Q24 revenue of $4.5 million vs. consensus/our estimate of $5.6 million. System revenue was $0.2 million vs. consensus of $1.3 million and our estimate of $1.5... More
